Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 21, 2025 12:20 ET | Source: Applied Stemcell

Applied StemCell Appoints Dolores Baksh, Ph.D., as Chief Executive Officer

Applied StemCell welcomes Dolores Baksh, Ph.D., as new CEO.
July 21, 2025 12:30 ET | Source: Custom Market Insights

[Latest] Global Cardiac Tissue Engineering Market Size/Share Worth USD 2,943.92 Million by 2034 at a 16.65% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, July 21, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cardiac Tissue Engineering Market Size, Trends and Insights By Material...
June 24, 2025 12:24 ET | Source: Applied Stemcell

Applied StemCell Launches hiEX™ Research iPSC Exosomes to Power Next-Generation Regenerative Medicine Research

Applied StemCell launches hiEX™ Research iPSC Exosomes, designed as a scalable and consistent source of exosomes for regenerative medicine research.
April 28, 2025 09:30 ET | Source: Custom Market Insights

[Latest] Global Regenerative Medicine Market Size/Share Worth USD 248.73 Billion by 2034 at a 19.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, April 28, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Regenerative Medicine Market Size, Trends and Insights By Product (Serum-free...
July 06, 2023 07:00 ET | Source: LIfT BioSciences

LIfT BioSciences heralds a new era of affordable effective cancer cell therapies simply produced from iPSCs

LIfT BioSciences heralds a new era of affordable effective cancer cell therapies simply produced from iPSCs LIfT announces successful production of first-in-class neutrophil based cell therapy from...
July 06, 2023 02:00 ET | Source: LIfT BioSciences

LIfT BioSciences heralds a new era of affordable effective cancer cell therapies simply produced from iPSCs

LIfT BioSciences heralds a new era of affordable effective cancer cell therapies simply produced from iPSCs LIfT announces successful production of first-in-class neutrophil based cell therapy from...
March 29, 2022 10:56 ET | Source: Cytovia Therapeutics

Cytovia Therapeutics’ Leadership to Present at Upcoming Conferences

AVENTURA, Fla. and NATICK, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell...